Fusion Pharmaceuticals ROCE Ratio 2011-2026 | FUSN

Annual ROCE Ratio Fusion Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-44.6	-54.27	-35.43	-12.69	-	-38.5	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-12.69	-54.27	-37.1

Quarterly ROCE Ratio Fusion Pharmaceuticals

2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-48.57	-35.83	-48.82	-51.53	-48.07	-32.22	-40.14	-35.06	-35.71	-24.6	-28.1	-23.69	-15.83	-8.94	3.48	19.41	33.56	24.09	24.09	11.67	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
33.56	-51.53	-18.04

ROCE Ratio of other stocks in the Biotechnology industry

Issuer	ROCE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	2.89	-	2.43 %	$ 254 M	Germany
Alnylam Pharmaceuticals ALNY	63.56	$ 330.79	3.74 %	$ 43.3 B	USA
BioLineRx Ltd. BLRX	-104.07	$ 2.34	5.72 %	$ 908 M	Israel
Alexion Pharmaceuticals, Inc. ALXN	17.36	-	-	$ 40.3 B	USA
Genfit SA GNFT	-49.48	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-325.06	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	-337.43	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-61.36	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	167.74	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	-196.79	-	-	$ 86.2 M	USA
Advaxis ADXS	429.74	-	-9.65 %	$ 45.9 M	USA
Anavex Life Sciences Corp. AVXL	-54.19	$ 3.01	0.5 %	$ 257 M	USA
Applied Molecular Transport AMTI	-209.11	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	-29.95	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	64924.32	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	-80.33	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	-29.3	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-60.13	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	-38.05	-	-	$ 3.67 B	USA
Akouos AKUS	-37.16	-	0.23 %	$ 488 M	USA
Институт стволовых клеток человека ISKJ	15.18	-	-	-	Russia
Allena Pharmaceuticals ALNA	-252.54	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	-32.41	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	-299.27	-	10.36 %	$ 9.8 M	USA
Aquestive Therapeutics AQST	211.07	$ 4.11	-0.48 %	$ 439 M	USA
Aravive ARAV	-664.7	-	-13.39 %	$ 1.45 M	USA
Arcturus Therapeutics Holdings ARCT	-35.64	$ 8.24	2.55 %	$ 226 M	Israel
Aptose Biosciences APTO	-46.69	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-163.42	-	-39.0 %	$ 4.57 M	USA
CureVac N.V. CVAC	-51.5	-	-	$ 867 M	Germany
AstraZeneca PLC AZN	11.12	-	-	$ 96.9 B	Britain
Celldex Therapeutics CLDX	-54.51	$ 31.36	0.97 %	$ 2.08 B	USA
Avenue Therapeutics ATXI	-168.29	-	-52.27 %	$ 4.45 M	USA
AVROBIO AVRO	10.76	-	1083.1 %	$ 745 M	USA
Axcella Health AXLA	-1848.9	-	-16.42 %	$ 249 M	USA
Arcutis Biotherapeutics ARQT	-6.45	$ 23.46	-0.72 %	$ 2.98 B	USA
Ayala Pharmaceuticals AYLA	3412.47	-	-	$ 7.46 M	Israel
BeiGene, Ltd. BGNE	7.03	-	0.49 %	$ 251 B	Cayman-islands
BioNTech SE BNTX	-4.81	$ 90.94	-0.26 %	$ 27.2 B	Germany
bluebird bio BLUE	-125.56	-	-	$ 546 M	USA
Allakos ALLK	-116.14	-	-	$ 28.6 M	USA
Brickell Biotech BBI	-64.05	-	-5.38 %	$ 6.06 M	USA
Ardelyx ARDX	-24.54	$ 6.01	1.18 %	$ 1.45 B	USA
Atreca BCEL	-34.9	-	-11.76 %	$ 5.79 M	USA
CASI Pharmaceuticals CASI	-49.51	-	-	$ 35.4 M	USA
Ampio Pharmaceuticals AMPE	-75.24	-	-11.43 %	$ 502 K	USA
ChemoCentryx CCXI	-45.41	-	-	$ 3.74 B	USA
AlloVir ALVR	-58.56	-	4.14 %	$ 49.1 M	USA
argenx SE ARGX	-211.69	$ 749.21	0.37 %	$ 25 B	Niderland